```html

Intracranial Pressure Increase (ICP)

What is Intracranial Pressure Increase?

Intracranial pressure (ICP) refers to the pressure exerted by the brain tissue, blood, and cerebrospinal fluid (CSF) within the rigid skull. A normal ICP ranges from 5 to 15 mm Hg in an adult at rest. Intracranial pressure increase (often called elevated ICP or intracranial hypertension) occurs when this pressure rises above the normal range, typically over 20–25 mm Hg. Because the skull cannot expand, any rise in volume—whether from swelling, bleeding, or fluid accumulation—forces pressure upward, potentially compromising cerebral blood flow, damaging brain tissue, and threatening life.

Understanding why ICP rises, recognizing the warning signs, and seeking prompt medical care are essential for preventing permanent neurologic injury.

Common Causes

Many conditions can increase the volume inside the cranium, leading to a rise in pressure. The most frequent causes include:

• Traumatic brain injury (TBI) – bruising, contusions, or bleeding after a blow to the head.
• Intracranial hemorrhage – subdural, epidural, subarachnoid, or intracerebral bleeding.
• Brain tumors – primary (gliomas, meningiomas) or metastatic lesions.
• Hydrocephalus – excess production or impaired absorption of CSF.
• Cerebral edema – swelling due to stroke, infection, or high altitude.
• Infections – meningitis, encephalitis, or brain abscesses that provoke inflammation.
• Venous sinus thrombosis – clotting in the brain’s large venous channels.
• Idiopathic intracranial hypertension (IIH) – increased ICP without a clear structural cause, often seen in overweight women of childbearing age.
• Severe hypertension or systemic disease – e.g., hypertensive encephalopathy, severe hypothyroidism.
• Medications or toxins – high‑dose vitamin A, tetracyclines, or lithium can raise ICP.

Associated Symptoms

The brain reacts to rising pressure in several characteristic ways. Commonly reported symptoms include:

• Headache – often described as a “pressure” or “tight band” feeling, worse when lying down.
• Nausea & vomiting – especially vomiting that is not preceded by nausea.
• Blurred or double vision – due to cranial nerve VI (abducens) palsy or papilledema.
• Altered mental status – confusion, drowsiness, or difficulty concentrating.
• Seizures – focal or generalized, particularly with hemorrhage or tumor.
• Changes in pupil size – one pupil may become enlarged (blown) as pressure compresses the oculomotor nerve.
• Loss of coordination – trouble walking, clumsiness, or ataxia.
• Speech difficulties – slurred or incoherent speech.
• Ear “whooshing” sounds (pulsatile tinnitus) – a sign of raised pressure transmitted to the inner ear.

When to See a Doctor

Because elevated ICP can progress quickly, you should seek medical attention promptly if you experience:

• Sudden, severe headache that feels different from usual migraines.
• Vomiting that occurs more than once and is not related to food intake.
• New or worsening confusion, lethargy, or difficulty staying awake.
• Visual disturbances such as double vision, loss of peripheral vision, or seeing “flashes”.
• Weakness or numbness affecting one side of the body.
• Head trauma, even if initially mild, followed by any of the symptoms above.
• Persistent neck stiffness or fever (possible meningitis).

When in doubt, call your healthcare provider or go to an emergency department. Early evaluation can prevent irreversible brain injury.

Diagnosis

Physicians combine a thorough history, physical examination, and targeted tests to confirm elevated ICP and identify its cause.

Clinical Examination

• Neurologic exam – assessment of eye movements, pupillary reactions, motor strength, and sensation.
• Fundoscopic exam – looking for papilledema (optic disc swelling).
• Assessment of vital signs – hypertension or bradycardia may suggest Cushing’s triad, a classic sign of high ICP.

Imaging Studies

• CT scan (non‑contrast) – rapid detection of hemorrhage, mass effect, or hydrocephalus.
• MRI – more detailed view of tumors, edema, and smaller lesions.
• CT or MR venography – evaluates venous sinus thrombosis.

Intracranial Pressure Monitoring

In severe or uncertain cases, a neurosurgeon may place an external ventricular drain (EVD) or a fiber‑optic intraparenchymal monitor. These devices provide real‑time pressure readings and can also be used to drain excess CSF.

Additional Tests

• Lumbar puncture – measures opening pressure and obtains CSF for infection or inflammatory analysis (contraindicated if mass effect is present).
• Blood work – CBC, electrolytes, coagulation profile, inflammatory markers.
• Visual field testing – especially in idiopathic intracranial hypertension.

Treatment Options

Therapy focuses on three goals: reduce the pressure, treat the underlying cause, and prevent recurrence. The approach varies with severity and etiology.

Immediate Medical Management

• Head elevation – 30°–45° to promote venous drainage.
• Hyperventilation (short‑term) – lowers PaCO₂, causing cerebral vasoconstriction; used only as a bridge to definitive treatment.
• Osmotic agents – Mannitol (0.25–1 g/kg IV) or hypertonic saline (3% – 23.4%) draw fluid out of brain tissue.
• Sedation & analgesia – reduces metabolic demand and prevents pain‑induced spikes in ICP.
• Controlled ventilation – maintain PaCO₂ 35–40 mm Hg to avoid hypocapnia‑induced ischemia.

Definitive Treatment by Etiology

• Trauma or hemorrhage – surgical evacuation of hematoma, decompressive craniectomy if swelling is massive.
• Brain tumors – surgical resection, radiation, or chemotherapy as appropriate.
• Hydrocephalus – ventriculoperitoneal (VP) shunt or endoscopic third ventriculostomy.
• Infection – antimicrobial therapy for meningitis/brain abscess plus possible drainage.
• Venous sinus thrombosis – anticoagulation (usually low‑molecular‑weight heparin) despite the presence of hemorrhage in most cases.
• Idiopathic intracranial hypertension – weight loss, acetazolamide (carbonic anhydrase inhibitor), topiramate, or surgical options (optic nerve sheath fenestration, CSF diversion).

Home & Lifestyle Measures (after stabilization)

• Maintain a normal fluid balance – avoid excessive IV fluids or severe dehydration.
• Limit caffeine and nicotine, which can cause vasoconstriction and spikes in pressure.
• Gradual weight loss (5–10% of body weight) for patients with IIH.
• Adhere to prescribed medications and follow‑up imaging schedules.
• Learn to recognize early warning signs and seek care promptly.

Prevention Tips

While some causes (e.g., genetic tumors) cannot be avoided, many risk factors are modifiable:

• Wear protective headgear during high‑risk activities (cycling, contact sports, construction).
• Control blood pressure and diabetes to reduce the risk of hemorrhagic stroke.
• Practice safe sex and avoid intravenous drug use to lower infection risk.
• Maintain a healthy weight and regular exercise—especially important for IIH.
• Avoid medications known to raise ICP unless directed by a physician (high‑dose vitamin A, tetracyclines).
• Stay up‑to‑date on vaccinations (e.g., meningococcal, pneumococcal) that protect against meningitis.
• Seek prompt evaluation for persistent or worsening headaches, visual changes, or neurological deficits.

Emergency Warning Signs

Key Take‑aways

Elevated intracranial pressure is a medical emergency that can result from trauma, bleeding, tumors, infections, or idiopathic causes. Recognizing its hallmark symptoms—headache, vomiting, visual changes, and altered consciousness—allows for rapid evaluation and treatment. Diagnostic tools such as CT/MRI, fundoscopic exams, and direct pressure monitoring guide therapy, which may range from medication and positioning to surgical decompression. Preventive measures focus on safety, chronic disease control, and healthy lifestyle habits. If any red‑flag signs develop, seek immediate medical care to protect brain function and life.

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, and peer‑reviewed articles in Journal of Neurosurgery and Neurology (2020‑2023).

```